Job Title: Senior Vice Principal, Strategic Partnerships
Job Type: Permanent
Site Locations: Abingdon, Oxfordshire or Alderley Park, Macclesfield
This role is remote, but must be located near to one of the above sites.
Evotec is a leader in the discovery and development of novel small molecule drugs with operational sites in Europe and the US. The Company has built substantial drug discovery expertise and an industrialised platform that can drive new innovative small molecule compounds into the clinic. In addition, Evotec has built a deep internal knowledge base in the treatment of diseases related to neuroscience, pain, oncology, inflammation and metabolic diseases. Leveraging these skills and expertise the Company intends to develop best-in-class differentiated therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies.
Evotec seeks a senior leader to shape and execute its next generation of strategic partnerships. The SVP Strategic Partnerships will design and secure long-term, innovation-driven alliances with global pharmaceutical companies, emerging biotechs, and ecosystem partners. The mandate is portfolio-focused and forward-looking. This role anticipates where science, technology, and capital will converge over the next 5 to 10 years and translates that view into differentiated, high-impact collaborations. The objective is to unlock the full potential of Evotec’s precision medicine and multimodal discovery platforms through structured, scalable partnerships that generate durable value.
The role requires deep scientific credibility, advanced deal architecture capability, and the ability to influence executive and board-level stakeholders across the life sciences industry.
Evotec offers a differentiated precision medicine and multimodal discovery platform designed for long-term value creation. This role provides the opportunity to shape strategic alliances that define future therapeutic landscapes and accelerate the development of transformative medicines globally.
Active Communication: Communicates actively, working on further clarity and responsiveness.
Constructive Feedback: Actively seeks and provides constructive feedback, using it to improve processes and outcomes.
Consistent Team Engagement: Engages frequently, fostering a more positive and collaborative environment.
Foundational Direction Sharing: Communicates pragmatic directions, leading to general understanding and alignment.
Occasional Planning: Begins anticipating problems and improves on proactively taking precautions.
Effective Delegation: Delegates tasks effectively, trusting team members to handle responsibilities and providing necessary support and development.
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.
Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients.
Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing.
We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI.
We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.
